National News

Change of pharmacy circumstance guide: ODS codes and planning required should your ODS code change (July 2018)

PSNC News - 2 hours 1 min ago

This briefing for pharmacy contractors explains pharmacy ODS (F) codes and those actions needed if your pharmacy circumstances are going to change (e.g. location or ownership).

Pharmacy relocation, closures or sales are subject to regulatory requirements, but this briefing focuses on mitigating IT/Electronic Prescription Service (EPS) impacts where such changes are planned.  PSNC recommends that pharmacy contractors planning such changes work through all of this guide and give the local NHS England team an absolute minimum of one month’s notice of the planned date for the change. The full transition period lasts for at least one month.

PSNC Briefing 038/18: Change of pharmacy circumstance guide: ODS codes and planning required should your ODS code change (July 2018)

If you have any queries on this PSNC Briefing or you require more information, please contact Daniel Ah-Thion, Community Pharmacy IT Lead.

To browse other PSNC briefings on Contract and IT, click here.

View Article…

Categories: National News

Public and bank holiday opening requirements

PSNC News - 9 hours 29 min ago

Community pharmacy contractors are permitted to close their pharmacies on most public and bank holidays, but there are some exceptions that they should be aware of.

It is important to take note of which days pharmacies can close without giving notice because, on those days, the hours that the pharmacy would ordinarily have been open will be treated as having been open for the purpose of counting the core contractual hours that week (i.e. there is no requirement to meet those hours on other days).

Pharmacies do not have to open on days which are specifically mentioned in the Regulations (namely Christmas Day, Good Friday and Easter Sunday) or a day which has been specifically designated as a ‘bank holiday’, unless directed to open by their local NHS England team.

Some bank holidays can occasionally cause confusion, for example, if New Year’s Day falls on a Sunday then the designated bank holiday would be the Monday. That would mean any pharmacy that normally opens on a Sunday would still have to open as usual on New Year’s Day, unless they have been granted permission to close by their local NHS England team.

For 2019, all NHS community pharmacies in England will not be required to open on the following days (unless otherwise directed by their local NHS England team):

  • New Year’s Day (1st January 2019)
  • Good Friday (19th April 2019)
  • Easter Sunday (21st April 2019)
  • Easter Monday (22nd April 2019)
  • Early May Bank Holiday (6th May 2019)
  • Spring Bank Holiday (27th May 2019)
  • Summer Bank Holiday (26th August 2019)
  • Christmas Day (25th December 2019)
  • Boxing Day (26th December 2019)

PSNC’s annual opening hours factsheet provides contractors with a quick reference guide on which public and bank holidays pharmacies can close without giving notice. The factsheet for 2019 was published in the July 2018 CPN and is available to download here.

Categories: National News

PSNC July Meeting: summary for contractors now available

PSNC News - 20 July 2018 - 4:58pm

PSNC’s July meeting was held on the 10th and 11th of the month in Crewe, and key agenda items included:

  • Category M, margins and the significant financial pressure that contractors are currently experiencing;
  • Potential amendments to NUMSAS that would help to improve the service;
  • The 2018/19 flu vaccination service;
  • Ongoing support for LPCs ranging from local commissioning to HR; and
  • Parliamentary lobbying activity in collaboration with other pharmacy organisations.

Download the summary of the July PSNC meeting here.

Further details regarding PSNC’s ongoing work will be shared on the website as soon as possible.

Categories: National News

PSNC tells MPs of impact of generics price increases on pharmacy workload

PSNC News - 20 July 2018 - 4:51pm

PSNC has given evidence to an investigation by the Public Accounts Committee (PAC) into price increases in generic medicines.

The cross-party group of MPs, who scrutinise the value for money of public spending, investigated after the National Audit Office found that the NHS spent £4.3 billion on generic medicines in 2016/17.

In its written evidence to the inquiry, PSNC explained the price concessions system and highlighted the impact that the generics shortages and price rises of last year had on community pharmacies.

Highlighting the work done by community pharmacies

In an evidence session on July 4th, Mark Burdon, PSNC Regional Representative for the North East and Cumbria, told MPs on the PAC about the thousands of reports that PSNC had received about shortages. He also described the work that community pharmacies had done to ensure that no patients were harmed.

“The workload involved in sourcing medicines and communicating with GPs, patients and hospital consultants is vast,” Mr Burdon said.

During the session Mr Burdon also:

  • Described the work pharmacies had done to ensure that all patients received their medicines, including staging supplies or suggesting therapeutic switches;
  • Outlined the inconvenience that shortages could cause for patients, who were sometimes left anxious about receiving their medicines;
  • Stressed the effectiveness of community pharmacy purchasing in keeping generics prices in the UK low; and
  • Explained how community pharmacists would like to be able to do more to help patients to understand and best take their medicines.

Read PSNC’s written submission to the Public Accounts Committee

Read the transcript of the evidence session on July 4th (or watch a video of the evidence session here)

Department of Health and Social Care and NHS England evidence

The PAC also heard evidence from representatives of the Department of Health and Social Care (DHSC), the Medicines and Healthcare products Regulatory Agency (MHRA) and NHS England.

The DHSC described how it had responded when it began to see reports of price rises in July, stressing that although price concessions had been expensive, no patients that they were aware of had been harmed. All three organisations were hopeful that new powers allowing them better access to information from across the supply chain would help to ensure that swift action could be taken in shortage situations in the future.

Dr Bruce Warner, NHS England’s Deputy Chief Pharmaceutical Officer, told the MPs: “We have no evidence of patient harm as a result of these price increases, and I think a lot of that is due to the work, which we should acknowledge, of the whole supply chain, including the community pharmacy network, and their professionalism and diligence in putting patients first and making that patients do get their supplies.”

Bridget Phillipson MP, a member of the PAC, quoted from evidence she had received from Sunderland LPC and noted the financial squeeze that many pharmacies were facing. She asked if we could do more to make better use of pharmacies and about the potential impact of online pharmacies. DHSC agreed that they wanted pharmacies to do more in terms of health prevention and advice, noting the need to balance NHS budgets, and suggested that a mixed model, of online and ‘classic’ community pharmacies, would likely be the way forward.

The PAC is expected to publish the report of its inquiry in the autumn.


Categories: National News

New Health Secretary sets out NHS priorities and role for pharmacies

PSNC News - 20 July 2018 - 1:11pm

Prevention, technology and the healthcare workforce are to be the top early priorities for the health service, the new Health Secretary has said today.

Simon Stevens’ priorities for the NHS

Earlier this week, NHS England Chief Executive Simon Stevens announced five long-term aims that will form part of the ten-year plan for the NHS due to be unveiled in the autumn.

These include:

  • Major improvements to mental health services, particularly for children and young people and in areas of core crisis care;
  • An overhaul to many aspects of cancer screening services, including early intervention and diagnostics;
  • A new focus around cardiovascular disease and outcomes for brain bleed strokes;
  • A renewed focus on children’s services, including prevention and inequality; and
  • New objectives for reducing health inequalities for people with learning disabilities, rough sleepers and the homeless.

Matt Hancock MP, who became  Secretary of State for Health and Social Care earlier this month, also spoke about investment  in community pharmacies to help people stay out of hospitals.

Mr Hancock made the comments during his first speech in his new role at West Suffolk Hospital. Setting out his ambition to make the NHS “the most advanced health system in the world”, he also pledged £487 million to transform technology in hospitals and help them to put in place electronics systems that save money and reduce medication errors.

Mr Hancock said that the NHS needs to take more of a holistic approach to prevention and “to make the investment in primary care and community pharmacies so people don’t need to go to hospital”. He also spoke of the need to stop the prescribing of unsophisticated drugs and instead wants to move towards new approaches, such as social prescribing.

Embracing electronic systems and technological innovations are key to Mr Hancock’s vision for the future of the health service. He said he wanted to work together with healthcare professionals to seize the opportunities of new technology.

PSNC Chief Executive Simon Dukes said:

“We are pleased to hear the new Secretary of State acknowledging the need for investment in community pharmacies so that they can do more to help ease pressure on hospitals. This is in line with PSNC’s ambitions – pharmacies are ideally placed to help people to stay healthy and avoid visits to hospital. We look forward to working with Government to make this shared vision a reality for the benefit of patients and the NHS.”

Categories: National News

MHRA Drug Safety Update – July 2018

PSNC News - 20 July 2018 - 12:47pm

Date issued: 17th July 2018

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 11, Issue 12, July 2018) has been published and includes articles on:

  • pressurised metered dose inhalers (pMDI): risk of airway obstruction from
    aspiration of loose objects;
  • eltrombopag (Revolade): reports of interference with bilirubin and creatinine test
    results; and
  • medicines taken during pregnancy: please report suspected adverse drug reactions, including in the baby or child, on a Yellow Card.

To see the latest MHRA Drug Safety Update in full, visit the website.

Categories: National News

SCRs with additional information – NHS Digital want your views

PSNC News - 20 July 2018 - 10:30am

NHS Digital has launched a survey to assess the benefits and disadvantages of ‘Additional Information’ being available for those healthcare staff who view Summary Care Records (SCR).

More than 96% of the English population has an SCR with the core information. Patients may also agree that their general practice adds other useful content beyond the core information. Over 1.6 million patients have consented to adding this additional information to their SCR and this number is rising by more than 18,000 patients each week.

When present in the GP health record, SCRs with additional information can contain the following:

  • Significant medical history and procedures (past and present);
  • Reason for medication;
  • Anticipatory care information (such as information about the management of long-term conditions);
  • Communication preferences (as per the Accessible information national dataset);
  • End of life care information (as per the Palliative Care Co-ordination national dataset);
  • Immunisations; and
  • Contact details for family, carers and healthcare professionals.

If this additional information is available to community pharmacists and pharmacy technicians, this is likely to have benefits for patient care provided by community pharmacies.

Pharmacy staff and others may take part by completing the online SCR additional information survey; it should take around 5-10 minutes to complete depending on your answers. The deadline for responding is 28th September 2018.

Categories: National News

CPAF screening process update and next steps

PSNC News - 20 July 2018 - 9:01am

Community pharmacy contractors responded positively to this year’s Community Pharmacy Assurance Framework (CPAF) screening questionnaire, with 98% completing the survey by the closing date.

The next stage of the CPAF monitoring process will begin shortly and PSNC has produced these FAQs to help contractors understand what is due to happen next.

Q. I submitted the CPAF screening questionnaire by the closing date; what happens next?
A. During September/October 2018, NHS England will visit around 2% of pharmacies to validate the answers given to the screening questionnaire. This selection of pharmacies will include some who have scored 3s for all questions in the screening questionnaire. These visits provide the opportunity for pharmacies to showcase added value and any local initiatives undertaken. The aim is for local NHS England teams to observe areas of good practice and also identify any situation where answers provided appear inconsistent with the evidence available.

Q. If I am selected to do the full CPAF questionnaire, when will I be invited to complete this?
A. The full CPAF questionnaire will be available for selected pharmacies to complete between Thursday 1st November and Sunday 2nd December 2018. NHS England will decide which pharmacies to invite to complete the full CPAF questionnaire. Some pharmacies are more likely to be asked to complete the full CPAF questionnaire taking into account factors and sources of information such as non-completion of the CPAF screening questionnaire and where there are concerns relating to patient safety.

Q. I completed the full CPAF questionnaire; does this mean my pharmacy will certainly be subject to a contract monitoring visit?
A. Not necessarily. In December 2018, NHS England will decide which pharmacies will be visited for contract monitoring purposes – it may be that NHS England decide not to visit a pharmacy following their more in-depth response, i.e. the full CPAF questionnaire. Once pharmacies have been selected then arrangements will be made for those visits to take place; these are expected to happen between January and March 2019.

Q. I haven’t been invited to complete the full CPAF questionnaire; can I complete it anyway?
A. Yes, you may choose to do so. A PDF of the full CPAF questionnaire for 2017/18 is currently available on the NHS Business Services Authority (NHS BSA) website for all pharmacies to access who wish to use it for training or self-assurance purposes.

Contractors can find out more information on the CPAF monitoring process outlined in the 2018/19 process in the contract monitoring section of the PSNC website.

Categories: National News

Category M reimbursement prices to increase from August 2018

PSNC News - 19 July 2018 - 3:30pm

Announcement Summary

Contractor Information

Category M reimbursement prices will increase by £15 million a month from August 2018, the Department of Health and Social Care (DHSC) has confirmed.

The increase is because DHSC has agreed to cease the £15 million per month reduction in prices that had been in place to recover estimated excess margin delivered to pharmacies in 2015/16 and 2016/17.

These reductions had been in place since August 2017 and had been set to continue. This was because the latest Margins Survey results from 2016/17 suggest that there was over-delivery of margin in that financial year, with some excess yet to be recovered by DHSC.

The decision to cease the Category M price reductions to recover margin now was a result of negotiations with PSNC in which we raised concerns about the impact of price reductions on contractors’ cash flow.

However, underlying Category M prices will continue to be based on manufacturers’ data so prices will still reflect the lower purchase prices that led to the additional reduction in prices seen in the July Tariff.

The Category M reimbursement price list for August 2018 can be found here. Prices have been uplifted by an average of 16% which equates to an increase in Average Item Value (AIV) of between 19 and 20 pence per item on all items.

PSNC Director of Pharmacy Funding Mike Dent said:

“The decision to cease margin recovery in the short-term in light of PSNC’s representations about contractors’ cash flow is very positive and reflective of the collaborative relationship that we are trying to rebuild with the DHSC.

PSNC will be working, through the negotiations on funding and in discussions with the Department, to get the best possible deal for contractors and to ensure that any future mechanisms to correct margin delivery are as manageable as possible in terms of cash flow.”

Frequently Asked Questions

Q.What is happening to Category M reimbursement prices in August?
Category M prices are affected by two factors:

  • the underlying manufacturers’ data; and
  • the margin required to make the supply chain work effectively.

In August, the underlying prices will carry on at levels introduced in the July Tariff, but prices will increase because the margin recovery has been removed. Prices will therefore be £15 million higher than they would otherwise have been had DHSC not agreed to suspend the recovery.

Q. For what months will these prices apply?
There will be a new Drug Tariff for August which will spread the £15 million uplift (because margins recovery has ceased) across the Category M products. This will apply for September as well.

Q. What will happen to prices from October?
In October there will be a new Drug Tariff based on manufacturers’ data.  At the moment the timing or quantum of any future adjustments are not known.

Q. How much excess margin has still not been recovered by DHSC?
A. The results of the Margins Surveys for 2016/17 and 2017/18 are still being analysed and discussed with DHSC. The survey for 2017/18 is taking far more work than usual because of the need to deal with the very many price concession lines set throughout the year.

Q. Is there any update on the funding negotiations and how does all this feed into those?
There is no update – funding negotiations for 2018/19 have not yet begun. The changes to Category M prices are part of PSNC’s ongoing work to ensure that the full amount of community pharmacy funding is delivered to contractors.

Categories: National News

Recognition for community pharmacy at MP briefing event

PSNC News - 18 July 2018 - 1:11pm

PSNC, working with LPCs and other pharmacy organisations, held a busy briefing event in Parliament yesterday (17th July) which 35 MPs attended.

The MPs, along with seven representatives from other MPs’ offices, heard about the role that community pharmacy can play in helping to support people with long-term conditions. They were briefed on how pharmacy teams can identify and treat long-term conditions in the community, help to keep people healthy and out of hospital, and reduce pressure on GPs and other parts of the health service. Many of them expressed support for the sector and PSNC and their LPCs will be following up with them over the summer. 

The event was sponsored by Sir Kevin Barron MP and Steve Double MP, who are both officers of the All-Party Pharmacy Group (APPG).

Pharmacists were on hand to provide check-ups and discuss any long-term conditions the attendees had, whilst LPC representatives gave local briefings on how the sector could do more to help constituents. Parliamentarians and their staff also heard about the sector’s shared vision and PSNC’s Care Plan proposal, and information was available on the APPG’s recent report on the care provided for people with long-term conditions.

An example of the local briefing  (a personalised version was produced for each MP who had accepted the event invitation)

PSNC has been sharing images and videos from the event on social media (see a selection below) and community pharmacy teams may wish to support this activity by using some of the tweet templates and photos below, or simply retweeting the messages and photos from PSNC’s Twitter account.

Tweet templates for 17th July event

PSNC is interested to hear feedback on the Care Plan proposal from those who work in community pharmacy. You can let us know what you think by completing our survey:

All-Party Pharmacy Group (APPG) Chair Sir Kevin Barron said:

“The pressure on the rest of the National Health Service around minor ailments, going into A&E and effectively blocking up doctors’ surgeries as well – these can be dealt with by community pharmacy. People are recognising that now. And of course, what we’re doing here today is looking at how people with long-term conditions can be better looked after by community pharmacy, not necessarily having to use the rest of our health service.”

APPG Vice-Chair Steve Double said:

“Today’s event here in Parliament is a great opportunity for MPs to come and hear about the absolutely vital role that community pharmacies play as part of the National Health Service. To understand more about the services they provide and also some of the challenge that they face as we review their role within the NHS. And I think it’s really important that we engage with MPs in this way so that they have a better understanding of the role of pharmacies as part of our comprehensive National Health Service.”

Download the full list of attendees

Images and videos of the attendees Tracy Brabin, MP for Batley and Spen: Laurence Robertson, MP for Tewkesbury:

Categories: National News

MHRA company-led drug alert – Melatonin 10mg capsules (IPS Specials)

PSNC News - 17 July 2018 - 5:29pm

CLDA number: CLDA (18)A/04

Date issued: 17th July 2018

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company-led drug recall for certain batches of:

Melatonin 10mg capsules (IPS Specials)

MDR number: MDR 022-07/18

IPS Specials is carrying out a company-led recall of two batches at pharmacy and wholesaler level as they have been labelled with an incorrect extended expiry date of 09 Apr 2021 when they should have been labelled as 26 Dec 2017.

To view the alert please visit the GOV.UK website.

Categories: National News

Dispensing & Supply monthly update (July 2018)

PSNC News - 16 July 2018 - 2:50pm

This briefing is part of a series issued regularly by PSNC to inform pharmacy contractors and pharmacy teams on monthly Drug Tariff changes, commonly asked questions and articles regarding dispensing and supply.

This briefing can also be found in the Dispensing & Supply section of July’s CPN.

PSNC Briefing 037/18: Dispensing & Supply monthly update (July 2018)

If you have any queries on this PSNC Briefing or you require more information, please contact the Dispensing & Supply Team.

To browse other PSNC briefings on dispensing and supply click here.

View Article…

Categories: National News

July edition of CPN magazine now available

PSNC News - 16 July 2018 - 2:48pm

The July 2018 edition of PSNC’s Community Pharmacy News (CPN) is now available. This month’s CPN features:

  • Endorsement guidance;
  • Flu Vaccination Service webinar;
  • Opening hours factsheet; and
  • CEO’s diary.

View our CPN magazine online via the flipbook reader below or download the PDF copy. Please note, the colour PDF can be printed out in black-and-white and will still be clear to read.

Categories: National News

Contract Factsheet – Pharmacy opening hours in 2019 (July 2018)

PSNC News - 16 July 2018 - 2:18pm

PSNC’s Regulations and Support Team are often asked questions about the requirements in the terms of service relating to opening hours. This briefing contains a quick reference guide for 2019.

PSNC Briefing 036/18: Contract Factsheet – Pharmacy opening hours in 2019

If you have queries on this PSNC Briefing or you require more information please contact William Goh, Regulations Officer.

To browse other PSNC briefings on Contract & IT, click here.

View Article…

Categories: National News

Community pharmacy organisations to brief MPs in Westminster

PSNC News - 16 July 2018 - 11:24am

Community pharmacy organisations are hosting a Parliamentary briefing event this week (Tuesday 17th July) to highlight the role that community pharmacy can play in helping to support people with long-term conditions.

With continued pressures on the NHS, growing demand from an aging population, and the King’s Fund warning of a “crisis” facing the health and care workforce, pharmacists will meet with MPs and peers to showcase how they can identify and treat long-term conditions in the community, help to keep people healthy and out of hospital, and reduce pressure on GPs and other parts of the health service.

The briefing event will take place in Portcullis House at Westminster and PSNC along with a number of LPCs will attend. Sponsored by All-Party Pharmacy Group (APPG) Officers Sir Kevin Barron MP and Steve Double MP, it will offer a chance for MPs to talk to pharmacists about any long-term conditions they have, and to receive a local briefing on how the sector could do more to help their constituents. Information will also be available on the APPG’s recent report on the care provided for people with long-term conditions.

The aim will be to highlight all that community pharmacies can do to help patients with long-term conditions and to make the case for the further development of pharmacy services in this area. MPs will be briefed on the sector’s shared vision and on PSNC’s Care Plan proposal.

Our thanks go to the many LPCs who have been supporting the event. Community pharmacy teams may also wish to join in with the activity by using some of the tweet templates below, or simply retweeting the messages and photos from PSNC’s Twitter account.

Tweet templates for 17th July event

Sir Kevin Barron MP, Chair of the All Party Parliamentary Group for Pharmacy, said:

“It is great to see what pharmacy is capable of and how it could provide more support for people with long-term conditions. The All-Party Pharmacy Group, which I chair, recently called for a wholesale upgrade of what the NHS provides for people with long-term conditions. For too long, people have been passed from pillar to post, with lots of variation in practice and uncoordinated care. We will continue to urge the Government to commission services from pharmacies to meet this need.”

Zoe Long, Acting Director of Communications and Public Affairs at PSNC, said:

“We are very pleased to be working with other pharmacy organisations to talk to MPs about our shared ambition for community pharmacies to provide more comprehensive care for people with long-term conditions. With the support of practising pharmacists and LPC representatives, we will outline not just what community pharmacy teams can do, but the benefits that this would have for patients and the NHS, as well as the enablers that are required to make our vision a reality.”

Categories: National News

Research concludes community pharmacist involvement in hypertension management does not increase GP workload

PSNC News - 15 July 2018 - 12:44pm

New research published in British Journal of General Practice examined referrals for patients with hypertension from community pharmacies to GPs as part of the New Medicine Service (NMS). Specifically, the study looks at what influences patient referrals within the first two weeks of starting an antihypertensive medicine – reportedly the first study of its kind.

The study looked at data from 131,419 patients, recorded using the original PharmOutcomes system and provided to the researchers by PSNC.

The data shows that a total of 5,895 patients were referred back to a GP within the first two weeks, which makes up 4.5% of the total sample. Patients reporting side effects from their new medication were most likely to be referred to their GP followed by patients who expressed uncertainty regarding the efficacy of the medicine. The majority of patients, 95.5% of the total sample, were supported by the pharmacist with no referral to the GP required.

The article concludes that additional pharmacist involvement in the management of patients with hypertension does not increase GP workload. It also suggests that an extended prescribing role for community pharmacists could reduce referrals of routine cases to GPs as medicines management is within their professional capacity.

Categories: National News

Name change for Appeals Unit

PSNC News - 13 July 2018 - 11:28am

From 2nd July 2018, the Family Health Services Appeal Unit (or FHSAU) has been renamed as the Primary Care Appeals service.

The Appeals service, which is part of NHS Resolution, ensures the prompt and fair resolution of appeals and disputes between primary care contractors and NHS England. Community pharmacy contractors and LPCs may come into contact with the service, for example, when an application for a new pharmacy is appealed or when a pharmacy has a request to change its core opening hours turned down by NHS England.

Whilst, the Primary Care Appeals service continues to be based at 1 Trevelyan Square, Leeds, LS1 6AE, it’s new contact email address is

Categories: National News

Drug Tariff Watch: August 2018 changes

PSNC News - 13 July 2018 - 8:44am

The Preface lists additions, deletions and alterations to the Drug Tariff. Below is a quick summary of the changes due to take place from 1st August 2018.

Part VIIIA additions

Category A:

  • Glycopyrronium bromide 600micrograms/3ml solution for injection ampoules (10)
  • *Sodium chloride 0.9% solution for injection 50ml vials (25)

Category C:

  • Adrenaline (base) 500micrograms/0.5ml (1 in 1,000) solution for injection pre-filled disposable devices SC (1) – Emerade
  • Alfentanil 1mg/2ml solution for injection ampoules (10) – Rapifen
  • Alprostadil 3mg/g cream (4) – Vitaros
  • Brivaracetam 100mg tablets (56) – Briviact
  • Brivaracetam 10mg tablets (14) – Briviact
  • Brivaracetam 25mg tablets (56) – Briviact
  • Brivaracetam 50mg tablets (56) – Briviact
  • Brivaracetam 75mg tablets (56) – Briviact
  • Carbimazole 10mg tablets (100) – Macleods Pharma UK Ltd
  • Carbimazole 15mg tablets (100) – Macleods Pharma UK Ltd
  • Ciprofloxacin 2mg/ml ear drops 0.25ml unit dose preservative free (15) – Cetraxal
  • Colestipol 5g granules sachets sugar free (30) – Colestid
  • Docusate 120mg/10g enema (6) – Norgalax
  • Fentanyl 100microgram sublingual tablets sugar free (10) – Abstral
  • Fentanyl 200microgram sublingual tablets sugar free (10) – Abstral
  • Fentanyl 300microgram sublingual tablets sugar free (10) – Abstral
  • Fentanyl 400microgram sublingual tablets sugar free (10) – Abstral
  • Fentanyl 600microgram sublingual tablets sugar free (30) – Abstral
  • Fentanyl 800microgram sublingual tablets sugar free (30) – Abstral
  • Guanfacine 1mg modified-release tablets (28) – Intuniv
  • Guanfacine 2mg modified-release tablets (28) – Intuniv
  • Guanfacine 3mg modified-release tablets (28) – Intuniv
  • Guanfacine 4mg modified-release tablets (28) – Intuniv
  • Hepatitis B (rDNA) 10micrograms/0.5ml vaccine suspension for injection pre-filled syringes SC (1) –Engerix B
  • Hepatitis B (rDNA) 20micrograms/1ml vaccine suspension for injection pre-filled syringes SC (1) – Engerix B
  • Insulin glulisine 100units/ml solution for injection 10ml vials SC (1) – Apidra
  • Insulin glulisine 100units/ml solution for injection 3ml cartridges (5) – Apidra
  • Levetiracetam 500mg/5ml solution for infusion vials (10) – Keppra
  • Liquid paraffin light 82.8% bath additive SC (500ml) – Cetraben emollient
  • Maraviroc 20mg/ml oral solution sugar free (230ml) – Celsentri
  • Maraviroc 25mg tablets (120) – Celsentri
  • Maraviroc 75mg tablets (120) – Celsentri
  • Methylphenidate 50mg modified-release capsules (30) – Medikinet XL
  • Methylphenidate 5mg modified-release capsules (30) – Medikinet XL
  • Methylphenidate 60mg modified-release capsules (30) – Medikinet XL
  • Ondansetron 4mg orodispersible films sugar free (10) – Setofilm
  • Ondansetron 8mg orodispersible films sugar free (10) – Setofilm
  • Potassium chloride 375mg/5ml (potassium 5mmol/5ml) oral solution sugar free (500ml) – Kay-Cee-L syrup
  • Proguanil 25mg / Atovaquone 62.5mg tablets (12) – Malarone Paediatric
  • Stiripentol 500mg oral powder sachets (60) – Diacomit
  • Tramadol 75mg modified-release tablets (60) – Zytram SR

Part VIIIA amendments

  • Aceclofenac 100mg tablets (60) – Preservex is changing to Category A
  • Calcipotriol 50micrograms/g ointment SC (30g) – Dovonex is changing to Category A
  • Carbamazepine 125mg suppositories (5) – Essential Pharma Ltd is changing to Category A
  • Isotretinoin 10mg capsules (30) – Roaccutane is changing to Category A
  • Morphine sulfate 30mg/1ml solution for injection ampoules (10) – Martindale Pharmaceuticals Ltd is changing to Category A
  • Simple linctus paediatric (200ml) – Thornton & Ross Ltd is changing to Category A
  • Tetrabenazine 25mg tablets (112) – Xenazine is changing to Category A

Part VIIIA deletions

If a medicinal product has been removed from Part VIIIA and has no other pack sizes listed, it can continue to be dispensed as long as the product does not appear in Part XVIIIA (the ‘Blacklist’)–but it will need to be endorsed fully (i.e. brand or supplier name from whom the product was purchased and the pack size from which the item was dispensed).

* This pack only (others already available)

  • Polymyxin B 10,000units/g / Bacitracin 500units/g ointment (20g) – Polyfax
  • *Sodium chloride 0.9% solution for injection 50ml vials (1)
  • Strontium ranelate 2g granules sachets sugar free (28) – Protelos

Part VIIIB additions

  • Clobetasone 0.05% / Oxytetracycline 3% / Nystatin 100,000units/g cream SC (30g)

Part IX deletions

It is important to take careful note of removals from Part IX because if you dispense a deleted product, prescriptions will be returned as disallowed.

Product Type, Size and Product Code Vaginal Contraceptive Diaphragm – Ortho All-Flex Diaphragm Arcing – Arcing Spring (Type C) 65-80mm (rising in 5mm) Capillary Action Absorbent Wound Dressing – Cerdak Aerocloth All sizes Capillary Action Absorbent Wound Dressing – Cerdak Aerofilm All sizes Capillary Action Absorbent Wound Dressing – Cerdak Basic All sizes Cavity Dressing – Cerdak Cavity All sizes WOUND MANAGEMENT DRESSINGS – ELECT Superabsorber Square (all sizes) and Rectangular (all sizes) ELASTIC HOSIERY – CLASS I Lt. Wt Elas. Net Thigh and Below Knee SPACER/HOLDING CHAMBER DEVICES – Fisio Chamber Vision All (with and without mask) ILEOSTOMY (DRAINABLE) BAGS – Hollister Ltd – Karaya 5 seal with microporous adhesive – 41cm Length Transparent 76mm (3276) TWO PIECE OSTOMY SYSTEMS – ConvaTec Ltd – Drainable Pouch with InvisiClose outlet and Filter (2-sided Comfort Backing) Opaque – Standard – Right (30.8cm) 13-48mm barrier (S1211F) TWO PIECE OSTOMY SYSTEMS – ConvaTec Ltd – Drainable Pouch with InvisiClose outlet and Filter (1-sided Comfort Backing) Transparent – Standard – Right (30.8cm) 13-35mm barrier (S1220F) CHEMICAL REAGENTS – DiaCheck 50 CHEMICAL REAGENTS – SuperCheck Plus 50 CHEMICAL REAGENTS – SuperCheck 2 50

Want to learn more about recent Dispensing & Supply news? Read our monthly updates here.

Categories: National News

Quality Payments: Last day to make your declaration!

PSNC News - 13 July 2018 - 8:30am

Today, Friday 13th July, is the last day that community pharmacy contractors can complete the Quality Payments online declaration on the NHS Business Services Authority (NHS BSA) website as it will close tonight at 11.59pm.

Contractors are reminded that once they have submitted their online declaration it cannot then be altered. It is therefore imperative that contractors check their declaration thoroughly before submitting their declaration on the website.

Once the declaration has been submitted the contractor will receive an email from NHS BSA confirming that the declaration has been successfully submitted and confirming the details that have been declared. This email should be retained by the pharmacy as proof that the declaration was submitted and the date of submission. The email will show how contractors have responded to each of the gateway and quality criteria.

NHS BSA has published a document which outlines the questions that will be asked so contractors can view these ahead of making their declaration.

FAQs on claiming Quality Payments can be found on the Quality Payments – FAQs page of the PSNC website.

Categories: National News

CPPE launches GDPR e-learning

PSNC News - 11 July 2018 - 3:34pm

The Centre for Pharmacy Postgraduate Education (CPPE) has published a General Data Protection Regulation (GDPR) e-learning programme for pharmacy professionals. The programme was developed on the back of the materials produced by the GDPR Working Group, which included representation from CPPE.

The aim of the e-learning is to develop the awareness, understanding and skills necessary for community pharmacy teams to implement the GDPR and associated legislation in order to make it work.

Categories: National News
Syndicate content